David Spaner

Medical Biophysics University of Toronto, Toronto, ON, Canada 
Medical Biophysics, Cell Biology, Biochemistry, Oncology, Immunology
"David Spaner"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Xia M, Luo TY, Shi Y, et al. (2020) Effect of Ibrutinib on the IFN Response of Chronic Lymphocytic Leukemia Cells. Journal of Immunology (Baltimore, Md. : 1950)
Spaner DE, McCaw L, Wang G, et al. (2019) Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial. Cancer Medicine
Liu T, Xia L, Yao Y, et al. (2019) Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death & Disease. 10: 117
Shi Y, Wang G, Muhowski EM, et al. (2019) Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells. Leukemia
Song J, Yuan C, Yang J, et al. (2018) Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia. The Febs Journal
Spaner DE, Venema R, Huang J, et al. (2018) Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia. Ebiomedicine
Zhu F, McCaw L, Spaner DE, et al. (2018) Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro. Leukemia Research. 66: 28-38
Sun L, Shi Y, Wang G, et al. (2017) PPAR-delta modulates membrane cholesterol and cytokine-signaling in malignant B cells. Leukemia
Li YJ, Sun L, Shi Y, et al. (2017) PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions. Leukemia
McCaw L, Shi Y, Wang G, et al. (2016) Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells. Ebiomedicine
See more...